Antibiotic eluting envelopes: evidence, technology, and defining high-risk populations.

Callahan, Thomas D; Tarakji, Khaldoun G; Wilkoff, Bruce L

Callahan, Thomas D; Tarakji, Khaldoun G; Wilkoff, Bruce L.

Affiliation

Callahan TD; Cardiac Electrophysiology and Pacing, Department of Cardiovascular Medicine, Cleveland Clinic 9500 Euclid Avenue, J2-2 Cleveland, OH 44195, USA.
Tarakji KG; Cardiac Electrophysiology and Pacing, Department of Cardiovascular Medicine, Cleveland Clinic 9500 Euclid Avenue, J2-2 Cleveland, OH 44195, USA.
Wilkoff BL; Cardiac Electrophysiology and Pacing, Department of Cardiovascular Medicine, Cleveland Clinic 9500 Euclid Avenue, J2-2 Cleveland, OH 44195, USA.

Europace ; 23(23 Suppl 4): iv28-iv32, 2021 06 23.

Article in En | MEDLINE | ID: mdl-34160597

Subject(s)

Defibrillators, Implantable; Pacemaker, Artificial; Prosthesis-Related Infections; Anti-Bacterial Agents/adverse effects; Antibiotic Prophylaxis; Humans; Prosthesis-Related Infections/diagnosis; Prosthesis-Related Infections/epidemiology; Prosthesis-Related Infections/prevention & control; Reproducibility of Results; Technology

Key words

Antibiotic envelope; Cardiac resynchronization; Cardiovascular implantable electronic devices; Implantable defibrillator; Infection; Pacemaker

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Pacemaker, Artificial / Prosthesis-Related Infections / Defibrillators, Implantable Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Europace Journal subject: CARDIOLOGIA / FISIOLOGIA Year: 2021 Type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google